Aspects Associated With Obstructive Sleep Apnea, Bruxism and Orofacial Pain
Study Details
Study Description
Brief Summary
This study evaluated the influence of the sleep bruxism (SB), awake bruxism (AB) and obstructive sleep apnea syndrome (OSAS) on the signs and symptoms of temporomandibular disorders (TMD).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Obstructive sleep apnea (OSA) is characterized by partial or total obstruction of the upper airways. Bruxism is defined as a repetitive activity of the mandibular musculature characterized by the tightening or grinding of the teeth and/or by the retrusion or propulsion of the mandible, and according to their manifestation circadian is defined as sleep bruxism (SB) or wake bruxism (AB). This prospective clinical study will be performed with adults (20 to 60 years) and elderly (> 60 years) (WHO-World Health Organization) who will be undergone polysomnography (PSG) at a private medical outpatients clinic from January to December 2019 to evaluate the influence of SB, AB, and OSA on signs and symptoms of TMD. The individuals will be assessed clinically and diagnosed for TMD using the "Diagnostic Criteria for Temporomandibular Disorders", for SB and OSA using PSG, and AB using the smartphone application. Specific statistical tests will be determined after preliminary analysis of the data (α= 0.05).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
with sleep bruxism, apnea and DTM Patients who will undergo analysis of: Evaluation of TMD and pain sensitivity Evaluation of SB Evaluation of AB |
Diagnostic Test: Evaluation of TMD and pain sensitivity
Extra and intraoral clinical examination will be performed and the Diagnostic Criteria for Temporomandibular Disorders (DC / TMD) questionnaire will be applied. Measurements shall be bilateral in the masseter, anterior temporal and tenar muscles and the arithmetic mean between three measurements will be considered the value for each side for pain sensitivity analysis with an dynamometer.
Diagnostic Test: Evaluation of SB
The presence or absence of SB will be diagnosed by Polysomnography
Diagnostic Test: Evaluation of AB
A smartphone will be used, which was developed for a momentary evaluation that allows a report of the exact moment of AB and its possible associated symptoms.
|
Outcome Measures
Primary Outcome Measures
- Polisomnography analysis [4 months after study start]
Patients included in the study will receive polisomnography exams for diagnosis of SB and OSAS. The data will be obtained from polisomnography records
Secondary Outcome Measures
- TMD assessment [6 months after study start]
All patients who had undergone polisomnography will answer the DC / TMD questionaire and clinical exams.
- Diagnosis of awake bruxism [8 months after study start]
All patients will use a Smartphone application after undergone polisomnography
- TMD pain [10 months after study start]
All patients who had undergone polisomnography will answer the DC / TMD questionaire and clinical exams with algometer.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adults (aged 20 to 60 years) and elderly (aged > 60 years) (WHO-World Health Organization, 2015) who will be undergone PSG at the Pelotas Sleep Institute (ISP);
-
Adequate cognitive capacity to understand and answer the questionnaire.
Exclusion Criteria:
• Those which the participants were unable to answer the questionnaires and who presented a history of epilepsy that could interfere in the results of PSG.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Noéli Boscato | Pelotas | RS | Brazil | 96015-560 |
Sponsors and Collaborators
- Federal University of Pelotas
Investigators
- Principal Investigator: Noéli Boscato, PhD, Federal University of Pelotas
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FUPelotas1